Precigen Insider Buying Surge Signals Cautious Optimism for Biotech Investors
Precigen insider Kirk Randal J buys 28,490 shares, adding 8 % stake—signaling cautious optimism for biotech investors and potential pipeline milestones.
4 minutes to read
Precigen Inc